These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26878123)

  • 21. Parkinson disease and exercise.
    Earhart GM; Falvo MJ
    Compr Physiol; 2013 Apr; 3(2):833-48. PubMed ID: 23720332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-based rehabilitation for Parkinson's disease: from neurons to neighborhoods.
    Hirsch MA
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S114-7. PubMed ID: 20082969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harnessing neurogenesis for the possible treatment of Parkinson's disease.
    Lamm O; Ganz J; Melamed E; Offen D
    J Comp Neurol; 2014 Aug; 522(12):2817-30. PubMed ID: 24723264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical and motor responses to acute forced exercise in Parkinson's disease.
    Alberts JL; Phillips M; Lowe MJ; Frankemolle A; Thota A; Beall EB; Feldman M; Ahmed A; Ridgel AL
    Parkinsonism Relat Disord; 2016 Mar; 24():56-62. PubMed ID: 26857399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease.
    Zhang J; Wang X; Li J; Huang R; Yu X; Dong C; Liu P; Zhang F; Hu J; Qi Y; Zhang J; Li Q; Yan B
    Biomed Res Int; 2016; 2016():5683097. PubMed ID: 27379248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifestyle Modulators of Neuroplasticity in Parkinson's Disease: Evidence in Human Neuroimaging Studies.
    Paola Caminiti S; Gallo S; Menegon F; Naldi A; Comi C; Tondo G
    CNS Neurol Disord Drug Targets; 2024; 23(5):602-613. PubMed ID: 37326116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Trial Highlights - Aerobic Exercise for Parkinson's Disease.
    Schootemeijer S; Darweesh SKL; de Vries NM
    J Parkinsons Dis; 2022; 12(8):2297-2306. PubMed ID: 36336942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of forced exercise cycling in individuals with Parkinson's disease.
    Miner DG; Aron A; DiSalvo E
    J Neurol Sci; 2020 Mar; 410():116677. PubMed ID: 31954353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autonomic nervous system as a source of biomarkers in Parkinson's disease].
    Pouclet H; Lebouvier T; Flamant M; Coron E; Neunlist M; Derkinderen P; Rouaud T
    Presse Med; 2012 Jul; 41(7-8):695-701. PubMed ID: 22284542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits.
    Calabresi P; Galletti F; Saggese E; Ghiglieri V; Picconi B
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S259-62. PubMed ID: 18267247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dance on motor functions, cognitive functions, and mental symptoms of Parkinson's disease: a quasi-randomized pilot trial.
    Hashimoto H; Takabatake S; Miyaguchi H; Nakanishi H; Naitou Y
    Complement Ther Med; 2015 Apr; 23(2):210-9. PubMed ID: 25847558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's disease and dystonia.
    Rothwell J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S417-20. PubMed ID: 18267274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early, severe and bilateral loss of LTP and LTD-like plasticity in motor cortex (M1) in de novo Parkinson's disease.
    Kishore A; Joseph T; Velayudhan B; Popa T; Meunier S
    Clin Neurophysiol; 2012 Apr; 123(4):822-8. PubMed ID: 21945457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's disease.
    Ansorge O; Daniel SE; Pearce RK
    Neurology; 1997 Aug; 49(2):610-3. PubMed ID: 9270609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroplasticity and Parkinson disease].
    Viallet F; Witjas T
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S42-8. PubMed ID: 12690663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions that improve body and brain bioenergetics for Parkinson's disease risk reduction and therapy.
    Mattson MP
    J Parkinsons Dis; 2014; 4(1):1-13. PubMed ID: 24473219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition and treatment of autonomic disturbances in Parkinson's disease.
    Li K; Reichmann H; Ziemssen T
    Expert Rev Neurother; 2015 Oct; 15(10):1189-203. PubMed ID: 26416396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
    Marek K; Jennings D; Tamagnan G; Seibyl J
    Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.